A Systematic Review and Meta-Analysis of Cerebrospinal Fluid Amyloid and Tau Levels Identifies Mild Cognitive Impairment Patients Progressing to Alzheimer’s Disease
出版年份 2022 全文链接
标题
A Systematic Review and Meta-Analysis of Cerebrospinal Fluid Amyloid and Tau Levels Identifies Mild Cognitive Impairment Patients Progressing to Alzheimer’s Disease
作者
关键词
-
出版物
Biomedicines
Volume 10, Issue 7, Pages 1713
出版商
MDPI AG
发表日期
2022-07-18
DOI
10.3390/biomedicines10071713
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Performance of plasma phosphorylated tau 181 and 217 in the community
- (2022) Michelle M. Mielke et al. NATURE MEDICINE
- Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
- (2022) Sakulrat Mankhong et al. Biomedicines
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study
- (2021) Elisabeth H Thijssen et al. LANCET NEUROLOGY
- CSF p-tau/Aβ42 ratio and brain FDG-PET may reliably detect MCI “imminent” converters to AD
- (2020) Roberto Santangelo et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Improved Differential Diagnosis of Alzheimer’s Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers
- (2019) Payam Emami Khoonsari et al. JOURNAL OF ALZHEIMERS DISEASE
- Combined Biomarker Prognosis of Mild Cognitive Impairment: An 11-Year Follow-Up Study in the Alzheimer’s Disease Neuroimaging Initiative
- (2019) Barbara E. Spencer et al. JOURNAL OF ALZHEIMERS DISEASE
- Characteristic Biomarker and Cognitive Profile in Incipient Mixed Dementia
- (2019) Carl Eckerström et al. JOURNAL OF ALZHEIMERS DISEASE
- Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid
- (2019) Anna Rosenberg et al. Alzheimers Research & Therapy
- Aging and Alzheimer’s disease: Comparison and associations from molecular to system level
- (2018) Xian Xia et al. AGING CELL
- Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment
- (2018) Inês Baldeiras et al. Alzheimers Research & Therapy
- Longitudinal Changes of CSF Biomarkers in Alzheimer's Disease
- (2018) Toni T. Seppälä et al. JOURNAL OF ALZHEIMERS DISEASE
- Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment
- (2018) Lucilla Parnetti et al. JOURNAL OF ALZHEIMERS DISEASE
- Current state of Alzheimer’s fluid biomarkers
- (2018) José Luis Molinuevo et al. ACTA NEUROPATHOLOGICA
- Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends
- (2017) Sergey O. Bachurin et al. MEDICINAL RESEARCH REVIEWS
- Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
- (2017) Piotr Lewczuk et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years
- (2017) Joakim Hertze et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range
- (2016) Dehui Luo et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Cerebrospinal fluid tau and amyloid-β1-42in patients with dementia
- (2015) Tobias Skillbäck et al. BRAIN
- The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin
- (2015) Douglas G. Peters et al. NEUROBIOLOGY OF DISEASE
- The age factor in Alzheimer’s disease
- (2015) Rita Guerreiro et al. Genome Medicine
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
- (2015) Xiang Wan et al. BMC Medical Research Methodology
- A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease
- (2014) Eric Karran et al. ANNALS OF NEUROLOGY
- Cognitive screening for dementia in primary care: a systematic review
- (2014) Juliana Emy Yokomizo et al. INTERNATIONAL PSYCHOGERIATRICS
- The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease
- (2013) X. Li et al. JOURNAL OF INTERNAL MEDICINE
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
- (2013) A. Prestia et al. NEUROLOGY
- Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
- (2013) L. E. Hebert et al. NEUROLOGY
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- Preclinical Alzheimer disease—the challenges ahead
- (2012) Reisa A. Sperling et al. Nature Reviews Neurology
- CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings
- (2012) T. T. Seppala et al. NEUROLOGY
- Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study
- (2012) Sebastian Palmqvist et al. PLoS One
- Combination of Hippocampal Volume and Cerebrospinal Fluid Biomarkers Improves Predictive Value in Mild Cognitive Impairment
- (2011) C. Eckerström et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- A Guide to Understanding Meta-analysis
- (2011) Heidi Israel et al. JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY
- CSF tau markers are correlated with hippocampal volume in Alzheimer's disease
- (2011) Leonardo C. de Souza et al. NEUROBIOLOGY OF AGING
- Mild Cognitive Impairment
- (2011) Ronald C. Petersen NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Multivariate Predictors
- (2011) Yue Cui et al. PLoS One
- Cerebrospinal Fluid Biomarkers and Prediction of Conversion in Patients with Mild Cognitive Impairment: 4-Year Follow-Up in a Routine Clinical Setting
- (2011) Alessia Lanari et al. TheScientificWorldJOURNAL
- The pathological process underlying Alzheimer’s disease in individuals under thirty
- (2010) Heiko Braak et al. ACTA NEUROPATHOLOGICA
- Tau in Alzheimer Disease and Related Tauopathies
- (2010) K. Iqbal et al. Current Alzheimer Research
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Subcortical Vascular Dementia Biomarker Pattern in Mild Cognitive Impairment
- (2009) Maria Bjerke et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Progression of Mild Cognitive Impairment to Alzheimer’s Disease: Improved Diagnostic Value of the Combined Use of N200 Latency and β-Amyloid(1–42) Levels
- (2009) V.T. Papaliagkas et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity
- (2009) Kajsa Sämgård et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Progression from MCI to AD: Predictive value of CSF Aβ42 is modified by APOE genotype
- (2009) Maartje I. Kester et al. NEUROBIOLOGY OF AGING
- Endpoints for trials in Alzheimer's disease: a European task force consensus
- (2008) Bruno Vellas et al. LANCET NEUROLOGY
- Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: A multicenter study
- (2007) Piotr Lewczuk et al. NEUROBIOLOGY OF AGING
- Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment
- (2007) Miroslaw Brys et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started